344 related articles for article (PubMed ID: 572413)
1. The effect of monoamine oxidase inhibitors on some arylalkylamines in rate striatum.
Philips SR; Boulton AA
J Neurochem; 1979 Jul; 33(1):159-67. PubMed ID: 572413
[No Abstract] [Full Text] [Related]
2. Reversible, amine--selective effects of acute and chronic brofaromine treatment in the rat.
Dyck LE; Boulton AA
Life Sci; 1992; 51(1):59-66. PubMed ID: 1614274
[TBL] [Abstract][Full Text] [Related]
3. The acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J-508: their properties and applications.
Fowler CJ; Oreland L; Callingham BA
J Pharm Pharmacol; 1981 Jun; 33(6):341-7. PubMed ID: 6115003
[No Abstract] [Full Text] [Related]
4. Influence of substrate in the inhibition of rat liver and brain monoamine oxidase.
Fuller RW
Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):32-7. PubMed ID: 4386711
[No Abstract] [Full Text] [Related]
5. Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain.
Garrick NA; Murphy DL
Psychopharmacology (Berl); 1980; 72(1):27-33. PubMed ID: 6781004
[No Abstract] [Full Text] [Related]
6. Multiple forms of monoamine oxidase. Comparison of in vitro and in vivo inhibition patterns.
Collins GG; Youdim MB; Sandler M
Biochem Pharmacol; 1972 Jul; 21(14):1995-8. PubMed ID: 4405452
[No Abstract] [Full Text] [Related]
7. Cumulative effects of irreversible MAO inhibitors in vivo.
Felner AE; Waldmeier PC
Biochem Pharmacol; 1979 Apr; 28(7):995-1002. PubMed ID: 444293
[No Abstract] [Full Text] [Related]
8. The effect of different substrates on the inhibition of rat brain and liver monoamine oxidase by arylalkylhydrazines.
Popov N; Matthies H; Lietz W; Thiemann C; Jassmann E
Biochem Pharmacol; 1970 Aug; 19(8):2413-8. PubMed ID: 5520601
[No Abstract] [Full Text] [Related]
9. Reciprocal changes in striatal dopamine and beta-phenylethylamine induced by reserpine in the presence of monoamine oxidase inhibitors.
Juorio AV; Greenshaw AJ; Wishart TB
Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec; 338(6):644-8. PubMed ID: 3149722
[TBL] [Abstract][Full Text] [Related]
10. Release of some endogenous trace amines from rat striatal slices in the presence and absence of a monoamine oxidase inhibitor.
Dyck LE
Life Sci; 1989; 44(17):1149-56. PubMed ID: 2716465
[TBL] [Abstract][Full Text] [Related]
11. Monoamine oxidase inhibitors and histamine metabolism.
Benedetti MS; Ancher JF; Sontag N
Experientia; 1980 Jul; 36(7):818-10. PubMed ID: 6772465
[TBL] [Abstract][Full Text] [Related]
12. Early effects of monoamine oxidase inhibitors on dopamine metabolism and monoamine oxidase activity in the neostriatum of the rat.
Javoy F; Youdim MB; Agid Y; Glowinski J
J Neural Transm; 1973; 34(4):279-89. PubMed ID: 4149516
[No Abstract] [Full Text] [Related]
13. Effect of monoamine oxidase inhibitors on qualitative alterations in enzymatic properties of mitochondrial monoamine oxidases.
Abdel Samed MH; Akopyan ZI; Veryovkina IV; Kulygina AA; Gorkin VZ
Biochem Pharmacol; 1971 Oct; 20(10):2571-7. PubMed ID: 5114498
[No Abstract] [Full Text] [Related]
14. Alteration of dopamine synthesis in rat striatum subsequent to selective type A monoamine oxidase inhibition.
Schoepp DD; Azzaro AJ
J Neurochem; 1981 Aug; 37(2):527-30. PubMed ID: 6790675
[TBL] [Abstract][Full Text] [Related]
15. Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs.
Neff NH; Yang HY
Life Sci; 1974 Jun; 14(11):2061-74. PubMed ID: 4603266
[No Abstract] [Full Text] [Related]
16. Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo.
Robinson DS; Lovenberg W; Keiser H; Sjoerdsma A
Biochem Pharmacol; 1968 Jan; 17(1):109-19. PubMed ID: 4384242
[No Abstract] [Full Text] [Related]
17. In vivo studies on the effect of monoamine oxidase inhibitors on dopamine and serotonin metabolism in rat brain areas.
Clement HW; Grote C; Wesemann W
J Neural Transm Suppl; 1990; 32():85-8. PubMed ID: 2128514
[No Abstract] [Full Text] [Related]
18. Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats.
Cabanillas AM; Masini-Repiso AM; Costamagna ME; Pellizas C; Coleoni AH
J Endocrinol; 1994 Nov; 143(2):303-8. PubMed ID: 7829993
[TBL] [Abstract][Full Text] [Related]
19. Molecular turnover numbers of different forms of mitochondrial monoamine oxidase in rat.
Egashira T; Ekstedt B; Kinemuchi H; Wiberg A; Oreland L
Med Biol; 1976 Aug; 54(4):272-7. PubMed ID: 957813
[TBL] [Abstract][Full Text] [Related]
20. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
Maître L
J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494
[No Abstract] [Full Text] [Related]
[Next] [New Search]
